Prospective randomized pilot study of Y90+/−sorafenib as bridge to transplantation in hepatocellular carcinoma-Reference-Cited by-同舟云学术

Prospective randomized pilot study of Y90+/−sorafenib as bridge to transplantation in hepatocellular carcinoma

Published:2014-08 Issue:2 Volume:61 Page:309-317
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Kulik Laura,Vouche Michael,Koppe Sean,Lewandowski Robert J.,Mulcahy Mary F.,Ganger Daniel,Habib Ali,Karp Jennifer,Al-Saden Patrice,Lacouture Mario,Cotliar Jonathan,Abecassis Michael,Baker Talia,Salem Riad

Publisher

Elsevier BV

Subject

Hepatology

Reference24 articles.

1. Hepatocellular carcinoma and hepatitis C in the United States;El-Serag;Hepatology,2002

2. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis;Mazzaferro;N Engl J Med,1996

3. Chemoembolization and radioembolization for hepatocellular carcinoma;Salem;Clin Gastroenterol Hepatol,2013

4. Treatment of unresectable primary and metastatic liver cancer with yttrium-90 microspheres (TheraSphere): assessment of hepatic arterial embolization;Sato;Cardiovasc Intervent Radiol,2006

5. Increased quality of life among hepatocellular carcinoma patients treated with radioembolization, compared with chemoembolization;Salem;Clin Gastroenterol Hepatol,2013

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multidisciplinary Delphi Consensus on Safety of Combining Transarterial Radioembolization with Yttrium-90 Microspheres with Systemic Anticancer Agents for the Treatment of Liver Malignancy;Journal of Vascular and Interventional Radiology;2024-09

2. Pioneering applications of immunotherapy in the early stages of hepatocellular carcinoma;Digestive and Liver Disease;2024-06

3. Hepatocellular Carcinoma: The Evolving Role of Systemic Therapies as a Bridging Treatment to Liver Transplantation;Cancers;2024-05-30

4. Applications of Yttrium-90 (90Y) in Hepatocellular Carcinoma;OncoTargets and Therapy;2024-02

5. Clinical consensus statement: Establishing the roles of locoregional and systemic therapies for the treatment of intermediate-stage hepatocellular carcinoma in Canada;Cancer Treatment Reviews;2023-04